Estrogen and oxidative stress: A novel mechanism that may increase the risk for cardiovascular disease in women

Richard E. White, Ross Gerrity, Scott A. Barman, Guichun Han

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Although early studies demonstrated that exogenous estrogen lowered a woman's risk of cardiovascular disease, recent trials indicate that HRT actually increases the risk of coronary heart disease or stroke. However, there is no clear explanation for this discrepancy. Is estrogen a helpful or a harmful hormone in terms of cardiovascular function? This review discusses some recent findings that propose a novel mechanism which may shed significant light upon this controversy. We propose that nitric oxide synthase (NOS) expressed within the vascular wall is a target of estrogen action. Under normal conditions in younger women, the primary product of estrogen action is NO, which produces a number of beneficial effects on vascular biology. As a woman ages, however, there is evidence for loss of important molecules essential for NO production (e.g., tetrahydrobiopterin, l-arginine). As these molecules are depleted, NOS becomes increasingly "uncoupled" from NO production, and instead produces superoxide, a dangerous reactive oxygen species. We propose that a similar uncoupling and reversal of estrogen response occurs in diabetes. Therefore, we propose that estrogen is neither "good" nor "bad", but simply stimulates NOS activity. It is the biochemical environment around NOS that will determine whether estrogen produces a beneficial (NO) or deleterious (superoxide) product, and can account for this dual and opposite nature of estrogen pharmacology. Further, this molecular mechanism is consistent with recent analyses revealing that HRT produces salutary effects in younger women, but mainly increases the risk of cardiovascular dysfunction in older postmenopausal women.

Original languageEnglish (US)
Pages (from-to)788-793
Number of pages6
JournalSteroids
Volume75
Issue number11
DOIs
StatePublished - Nov 1 2010

Fingerprint

Oxidative stress
Estrogens
Oxidative Stress
Cardiovascular Diseases
Nitric Oxide Synthase
Superoxides
Blood Vessels
Molecules
Medical problems
Coronary Disease
Arginine
Reactive Oxygen Species
Stroke
Hormones
Pharmacology

Keywords

  • Coronary
  • Estrogen
  • Hormone replacement therapy
  • Nitric oxide
  • Superoxide

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Endocrinology
  • Pharmacology
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Estrogen and oxidative stress : A novel mechanism that may increase the risk for cardiovascular disease in women. / White, Richard E.; Gerrity, Ross; Barman, Scott A.; Han, Guichun.

In: Steroids, Vol. 75, No. 11, 01.11.2010, p. 788-793.

Research output: Contribution to journalArticle

White, Richard E. ; Gerrity, Ross ; Barman, Scott A. ; Han, Guichun. / Estrogen and oxidative stress : A novel mechanism that may increase the risk for cardiovascular disease in women. In: Steroids. 2010 ; Vol. 75, No. 11. pp. 788-793.
@article{7de221388bd34713b476e91fbd6ff96d,
title = "Estrogen and oxidative stress: A novel mechanism that may increase the risk for cardiovascular disease in women",
abstract = "Although early studies demonstrated that exogenous estrogen lowered a woman's risk of cardiovascular disease, recent trials indicate that HRT actually increases the risk of coronary heart disease or stroke. However, there is no clear explanation for this discrepancy. Is estrogen a helpful or a harmful hormone in terms of cardiovascular function? This review discusses some recent findings that propose a novel mechanism which may shed significant light upon this controversy. We propose that nitric oxide synthase (NOS) expressed within the vascular wall is a target of estrogen action. Under normal conditions in younger women, the primary product of estrogen action is NO, which produces a number of beneficial effects on vascular biology. As a woman ages, however, there is evidence for loss of important molecules essential for NO production (e.g., tetrahydrobiopterin, l-arginine). As these molecules are depleted, NOS becomes increasingly {"}uncoupled{"} from NO production, and instead produces superoxide, a dangerous reactive oxygen species. We propose that a similar uncoupling and reversal of estrogen response occurs in diabetes. Therefore, we propose that estrogen is neither {"}good{"} nor {"}bad{"}, but simply stimulates NOS activity. It is the biochemical environment around NOS that will determine whether estrogen produces a beneficial (NO) or deleterious (superoxide) product, and can account for this dual and opposite nature of estrogen pharmacology. Further, this molecular mechanism is consistent with recent analyses revealing that HRT produces salutary effects in younger women, but mainly increases the risk of cardiovascular dysfunction in older postmenopausal women.",
keywords = "Coronary, Estrogen, Hormone replacement therapy, Nitric oxide, Superoxide",
author = "White, {Richard E.} and Ross Gerrity and Barman, {Scott A.} and Guichun Han",
year = "2010",
month = "11",
day = "1",
doi = "10.1016/j.steroids.2009.12.007",
language = "English (US)",
volume = "75",
pages = "788--793",
journal = "Steroids",
issn = "0039-128X",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Estrogen and oxidative stress

T2 - A novel mechanism that may increase the risk for cardiovascular disease in women

AU - White, Richard E.

AU - Gerrity, Ross

AU - Barman, Scott A.

AU - Han, Guichun

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Although early studies demonstrated that exogenous estrogen lowered a woman's risk of cardiovascular disease, recent trials indicate that HRT actually increases the risk of coronary heart disease or stroke. However, there is no clear explanation for this discrepancy. Is estrogen a helpful or a harmful hormone in terms of cardiovascular function? This review discusses some recent findings that propose a novel mechanism which may shed significant light upon this controversy. We propose that nitric oxide synthase (NOS) expressed within the vascular wall is a target of estrogen action. Under normal conditions in younger women, the primary product of estrogen action is NO, which produces a number of beneficial effects on vascular biology. As a woman ages, however, there is evidence for loss of important molecules essential for NO production (e.g., tetrahydrobiopterin, l-arginine). As these molecules are depleted, NOS becomes increasingly "uncoupled" from NO production, and instead produces superoxide, a dangerous reactive oxygen species. We propose that a similar uncoupling and reversal of estrogen response occurs in diabetes. Therefore, we propose that estrogen is neither "good" nor "bad", but simply stimulates NOS activity. It is the biochemical environment around NOS that will determine whether estrogen produces a beneficial (NO) or deleterious (superoxide) product, and can account for this dual and opposite nature of estrogen pharmacology. Further, this molecular mechanism is consistent with recent analyses revealing that HRT produces salutary effects in younger women, but mainly increases the risk of cardiovascular dysfunction in older postmenopausal women.

AB - Although early studies demonstrated that exogenous estrogen lowered a woman's risk of cardiovascular disease, recent trials indicate that HRT actually increases the risk of coronary heart disease or stroke. However, there is no clear explanation for this discrepancy. Is estrogen a helpful or a harmful hormone in terms of cardiovascular function? This review discusses some recent findings that propose a novel mechanism which may shed significant light upon this controversy. We propose that nitric oxide synthase (NOS) expressed within the vascular wall is a target of estrogen action. Under normal conditions in younger women, the primary product of estrogen action is NO, which produces a number of beneficial effects on vascular biology. As a woman ages, however, there is evidence for loss of important molecules essential for NO production (e.g., tetrahydrobiopterin, l-arginine). As these molecules are depleted, NOS becomes increasingly "uncoupled" from NO production, and instead produces superoxide, a dangerous reactive oxygen species. We propose that a similar uncoupling and reversal of estrogen response occurs in diabetes. Therefore, we propose that estrogen is neither "good" nor "bad", but simply stimulates NOS activity. It is the biochemical environment around NOS that will determine whether estrogen produces a beneficial (NO) or deleterious (superoxide) product, and can account for this dual and opposite nature of estrogen pharmacology. Further, this molecular mechanism is consistent with recent analyses revealing that HRT produces salutary effects in younger women, but mainly increases the risk of cardiovascular dysfunction in older postmenopausal women.

KW - Coronary

KW - Estrogen

KW - Hormone replacement therapy

KW - Nitric oxide

KW - Superoxide

UR - http://www.scopus.com/inward/record.url?scp=77955924308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955924308&partnerID=8YFLogxK

U2 - 10.1016/j.steroids.2009.12.007

DO - 10.1016/j.steroids.2009.12.007

M3 - Article

C2 - 20060403

AN - SCOPUS:77955924308

VL - 75

SP - 788

EP - 793

JO - Steroids

JF - Steroids

SN - 0039-128X

IS - 11

ER -